MDUFMA Branding Provision Reprieve To Be Explained In Upcoming Guidance

FDA will give manufacturers 18 months to implement branding provisions of the Medical Device User Fee & Modernization Act upon issuance of a final guidance explaining how firms may achieve compliance

More from Archive

More from Medtech Insight